Cardiac Sympathetic Imaging With mIBG in Heart Failure

Carrió, Ignasi; Cowie, Martin R; Yamazaki, Junichi; Udelson, James E; Camici, Paolo G

doi:10.1016/j.jcmg.2009.07.014

Record: found
Abstract: not found
Article: not found

Cardiac Sympathetic Imaging With mIBG in Heart Failure

Author(s): Ignasi Carrió , Martin R. Cowie , Junichi Yamazaki , James Udelson , Paolo G. Camici

Publication date Created: January 2010

Publication date (Print): January 2010

Journal: JACC: Cardiovascular Imaging

Publisher: Elsevier BV

Read this article at

ScienceOpenPublisher PubMed

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Cardiac sympathetic imaging with meta-iodobenzylguanidine (mIBG) is a noninvasive tool to risk stratify patients with heart failure (HF). In patients with ischemic and nonischemic cardiomyopathy, cardiac mIBG activity is a very powerful predictor of survival. Cardiac sympathetic imaging can help in understanding how sympathetic overactivity exerts its deleterious actions, which may result in better therapy and outcome for patients with HF. Copyright (c) 2010 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.